Recurrent Fusion of PCM1 to JAK2 in Atypical Chronic Myeloid Leukemia and Acute Leukemia Associated with the t(8;9)(p21-22;p23-24).
Andreas Reiter(Heidelberg University), Nicholas C.P. Cross(University of Southampton), Shilani Aruliah(University of Mannheim), Rüdiger Hehlmann(Heidelberg University), Nick Telford(University of Mannheim), Brigitte Schlegelberger(Heidelberg University), Andreas Hochhaus(Jena University Hospital), A. E. Watmore(University of Mannheim), Helen F. Barker(University of Mannheim), Ute Berger(Heidelberg University), Danny Vanstraelen(University of Mannheim), Peter Taylor(University Hospital of Wales), John Yin(University of Mannheim), Christoph Walz(Ludwig-Maximilians-Universität München), Aisling O’Driscoli(University of Mannheim), Andrew Chase(Wessex Regional Genetics Laboratory), Claudia Schoch, Ilona Blau(University of Mannheim)
Cited by 0
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k